Where trust meets care
Established in 1961, Ranbaxy Laboratories Limited (RLL) is proud to celebrate 50+ years of excellence in the healthcare industry. Over the years, Ranbaxy has grown to a multi-national organization with operations in more than 124 countries, across six continents, with over 14,000 employees spread around the globe, representing 51 different nationalities.
RLL entered the U.S. generic pharmaceutical market in 1995, introducing its first FDA approved product under the Ranbaxy Pharmaceuticals Inc. (RPI) label in January 1998. RPI opened its U.S. office in Raleigh, N.C., in January 1995 and acquired the manufacturing capabilities of Ohm Laboratories (Ohm) the same year. Subsequently, the company relocated to New Jersey in 1998. Today, Ranbaxy has U.S. operations in both New Jersey and Florida, while commercializing and distributing generic pharmaceutical products in all 50 states where at least one Ranbaxy product can be found on the shelves of the 55,000 pharmacies located in the U.S.
Ranbaxy is involved in all aspects of product development, from producing the active ingredient to formulating the dosage form, creating and filing an ANDA, manufacturing the finished dosage form, and ultimately marketing and distributing products to pharmacies throughout the U.S.
‘People First’ is not just a philosophy for us. It is the way we lead our lives at Ranbaxy every day. One of our biggest strengths is the diversity of our people and the rich experience that they bring across varied skill-sets, backgrounds and cultures. What binds all Ranbaxians together is the common thread called Values in Action. We believe in nurturing our people and ensuring their growth, alongside the growth of the organisation. Our people are at the heart of our business. They are responsible for having taken our organisation to the heights that it has scaled and are preparing themselves for its next big leap.
At Ranbaxy, we believe that human capital forms a critical part of an organization's portfolio of privileged assets. Ranbaxy is an international pharmaceutical company with over 14,000 employees. Whether in the manufacturing or administrative areas, we offer employees opportunities to play important roles in the development, manufacturing and marketing of our product line.
We offer the advantages of working in a mid-sized company where employees can have broader, more diverse roles and get to know others in many areas. The Ranbaxy of today provides a variety of opportunities for all employees to help build the Ranbaxy of tomorrow.
Ranbaxy is a dynamic, growing organization and is open to receiving resumes from qualified individuals. We seek educated candidates who are highly motivated, business-oriented and tech-savvy. Ranbaxy is an equal opportunity employer.
Autonomy and Entrepreneurship
Creativity and Innovation
In our organisation, there is a continuous and conscious effort to recognise excellence in performance through various global and local programmes across the company. Prompt and instant recognition is given to employees for exceptional performance through various recognition schemes. Regional and functional awards facilitate the recognition of employees’ involvement and inputs towards the realisation of the regional and functional goals. Our Global Appreciate Programme is a common platform for recognising exceptional performance across the globe.
Ranbaxy Inc. is the North American commercial arm of Ranbaxy Laboratories Limited (Ranbaxy), a research based international pharmaceutical company serving customers in more than 150 countries. In 1994, Ranbaxy entered the US healthcare system with a focus on the generic pharmaceutical sector. Ranbaxy Inc. is headquartered in Princeton, New Jersey.
Ranbaxy Laboratories Limited
With its global headquarters in India, Ranbaxy has ground operations in 43 countries and 21 manufacturing facilities spread across 8 countries. We cover all the top 25 pharmaceutical markets of the world and have a robust presence across both developed and emerging markets. Driven by the passion of our multicultural work force of over 14,600 employees, comprising more than 50 nationalities, we continue to aggressively pursue our mission of ‘Enriching lives globally, with quality and affordable pharmaceuticals’.
Ranbaxy Pharmaceuticals Inc.
Ranbaxy Pharmaceuticals Inc. (RPI), Ranbaxy’s wholly-owned subsidiary, began marketing generic products in the US in 1998 after receiving the first U.S. Food and Drug Administration (FDA) approval for Cefaclor, a broad-spectrum anti-infective agent. The US market is integral to Ranbaxy’s manufacturing operations and to its future growth worldwide.
Ranbaxy Laboratories Inc.
Ranbaxy Laboratories Inc. (RLI), also a wholly-owned subsidiary of Ranbaxy, is its branded prescription division in the US. We have been growing on the strength of Ranbaxy’s R&D efforts and relentlessly exploring Novel Drug Delivery Systems (NDDS), licensing activities, and acquisitions. We continue to expand the presence and visibility of Ranbaxy by bringing value-added branded products to the market.
Ohm Laboratories, Inc.
Ohm Laboratories, Inc. (Ohm), acquired by Ranbaxy in 1995, manufactures prescription and Over-the-Counter (OTC) drugs in solid dose forms (capsules and tablets) and is U.S. Drug Enforcement Agency (DEA) approved to manufacture controlled substances. Our state-of-the-art laboratory, manufacturing and warehousing facilities are capable of handling high-volume products and large batch sizes, while our supply chain efficiency ensures seamless transportation to customer locations. We are a frontrunner in bringing unique product deliveries and complex combinations to the market. We use cutting-edge technology to meet all our customer needs and offer full-service, customized marketing and promotional programs designed to meet the growing needs of retailers, wholesalers and consumers.
At Ohm, we are committed to meeting or exceeding U.S. Food and Drug Administration (FDA) standards for facilities, products, quality systems and procedures. Our facilities are routinely inspected and approved by the FDA, the DEA and the European Union. We employ the strictest standards in administering thorough testing and inspection at each stage of the manufacturing process. To continually monitor the quality of our products, each of them is subjected to impurity profiling exceeding industry standards.
Over the years, Ranbaxy has established itself in the US market as a capable player that offers a wide range of pharmaceutical products and whose focus remains market-driven and customer-responsive. We will continue to expand our product portfolio in the US market for the benefit of patients, prescribers and the US healthcare system.
Ranbaxy launches acne drug Absorica in US
Ranbaxy Laboratories Inc, the US-based wholly owned subsidiary of Ranbaxy Laboratories Limited, has launched of Absorica (isotretinoin) 25 mg and 35 mg capsules in the US. Absorica, a product licensed by Ranbaxy from Cipher Pharmaceuticals Inc, has become the most prescribed branded oral isotretinoin in the US, as per a recent independent survey conducted with dermatologists. It is indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older.
Due to its high lipophilicity, oral absorption of isotretinoin is enhanced when given with a high-fat meal, however, Absorica, which is formulated using patented Lidose technology, can be given without regards to meals. The fasted AUC0-t of Absorica is approximately 83 percent greater than that of Accutane, while both products are bioequivalent under fed conditions. Absorica is therefore not interchangeable and not substitutable with generic products of Accutane.
Dr Ashish Anvekar, Vice President of Brand Division North America, Ranbaxy, said “Since isotretinoin dosing is weight-based, we are most pleased to make available these valuable, additional dosing options exclusively for Absorica. This will give prescribers the enhanced flexibility, to tailor the isotretinoin therapy depending on the patient’s weight, and benefit the group of patients who are in that weight range, irrespective of their dietary intake. Ranbaxy continuously seeks to innovate and bring value based options to the specialty of dermatology and patients.”
Article courtesy of Business Standard http://www.business-standard.com/content/b2b-pharma/ranbaxy-launches-acne-drug-absorica-in-us-114100700563_1.html
The Vital Elements
Manufacturing is at the heart of all our operations. At this very moment, our people are working across the four continents in different time zones to manufacture quality medicines that you can trust. We produce the entire gamut of pharmaceutical offerings - Generics, Differentiated Products, Over-the-Counter Products, Anti-Retrovirals (ARVs), Active Pharmaceutical Ingredients (APIs) and Intermediates.
At each facility, at each state of manufacturing, quality receives the highest priority. Our facilities comply with Good Manufacturing Practices and meet the stringent standards of our global regulatory authorities around the world. Our technology is state-of-the-art and our infrastructure best-in-class.
Another outcome of our global manufacturing is that we are able to keep the costs down. This combined with supply chain efficiencies, enables us to make affordability the hallmark of our product pricing, allowing us to have a positive impact on the health and well-being of ever larger numbers of people around the world.
We continuously work on improvement of our product and processes to improve process capability and productivity.
I worked at Ranbaxy as an internPros
Offices have a community-like environment. Everyone is very willing to help and answer questions. There are plenty of opportunities to socialize, such as an employee softball team. Additionally, employees are encouraged to have a good work/life balance with early dismissals on Fridays during the summer.Cons
The traffic outside of the Princeton Forrestal Village becomes nightmarish around 4:30 pm and makes for a very difficult commute either northbound or southbound on route 1. Other than that I enjoyed my time there very much.
Getting an Interview
Getting an Interview
- Application Details
I applied through an employee referral. The process took 2+ weeks – interviewed at Ranbaxy in May 2010.Interview Details
I was interviewed for 2 different positions and was chosen for both. I was given the choice of both the job roles and the one I went with helped me be where i am today. This is a good place to work at if you can keep your ear to yourself.Interview Questions
Accepted OfferPositive ExperienceDifficult Interview
- Since I was just out of college they did not ask me very detailed stuff but was asked mainly technical questions which I was able to answer. Answer Question
Ranbaxy Laboratories is one of India's largest drug manufacturers and a top global generics producer. Anti-infectives amoxycillin (not to be confused with the common antibiotic, amoxicillin) and ciprofloxacin, and cardio drug simvastatin are among Ranbaxy's top sellers; all come in several administration forms. The company also makes treatments for gastrointestinal...
Mission: Mission: Enriching lives globally, with quality and affordable pharmaceuticals
Philosophy: Quality and Patients First